the possibility of a material adverse impact in our consolidated financial statements for the period in which the effects become reasonably estimable. NOTE 16 — STOCKHOLDERS’ EQUITY Shares Outstanding Shares of common stock outstanding were as follows: (In millions) Year Ended June 30, 2021 2020 2019 Balance, beginning of year 7,571 7,643 7,677 Issued 49 54 116 Repurchased (101) (126) (150) Balance, end of year 7,519 7,571 7,643 Share Repurchases On September 20, 2016, our Board of Directors approved a share repurchase program authorizing up to $40.0 billion in share repurchases. This share repurchase program commenced in December 2016 and